Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Plasma cell 1Lymphoid 1Gynecologic 1

Conditions

Multiple Myeloma 181Recurrence 26Neoplasms, Plasma Cell 16Smoldering Multiple Myeloma 4Neoplasms 4Lymphoma 4Leukemia, Plasma Cell 3Leukemia 2Disease 2Waldenstrom Macroglobulinemia 1Small Cell Lung Carcinoma 1Renal Insufficiency 1Plasmacytoma 1Ovarian Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myeloid, Acute 1Kidney Neoplasms 1Kidney Failure, Chronic 1Immunoglobulin Light-chain Amyloidosis 1Hodgkin Disease 1Hematologic Neoplasms 1Graft vs Host Disease 1Carcinoma, Non-Small-Cell Lung 1Bone Marrow Neoplasms 1Blast Crisis 1Anemia 1Amyloidosis 1

Interventions

fludarabine phosphate 4Cyclophosphamide 4Antilymphocyte Serum 4Mycophenolic Acid 3Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Methotrexate 2Filgrastim 2Cyclosporine 2Busulfan 2thymoglobulin 1sargramostim 1orantinib 1interferon-alfa-1b 1fludarabine 1cc-486 1carfilzomib 1aldesleukin 1Whole-Body Irradiation 1Voriconazole 1Stem Cell Transplantation 1Social Determinants of Health 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Interleukin-12 Subunit p35 1Interferons 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Kidney Neoplasms × carfilzomib × Plasma cell × Clear all
NCT00531284 2017-08-15

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

Amgen

Phase 1/2 Completed
184 enrolled 36 charts
GenitourinaryGynecologicLymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Lymphoma, Multiple Myeloma, Ovarian Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡